December 2015
12/14/15 Konrad Hochedlinger, HSCI Principal Faculty member, identified a gene that when suppressed helps cells lose their "memory," making them more susceptible to reprogramming into iPS cells. Featured: Science 2.0, GEN News, PhysOrg, HNGN, Science Codex, NewsWise
November 2015
11/23/15 The Boston Globe photographs HSCI co-founder and co-director Doug Melton at the Joslin Diabetes Center's16th annual High Hopes Gala. Melton received a Global Achievement Award that night.
11/19/15 HSCI co-founder and co-director David Scadden speaks with CBS Chicago about the lack of scientific evidence and literature backing stem cell clinics and treatment centers.
11/19/15 Boston Business Journal publishes a Q&A with HSCI co-founder and co-director Doug Melton, who received a Global Achievement Award from Joslin Diabetes Center in recognition of his contributions to the field of diabetes research.
October 2015
10/01/15 In The Scientist, an article exploring adult humans' ability to generate new neurons features the work of HSCI Principal Faculty Amar Sahay.
September 2015
09/22/15 BBC News references HSCI Principal Faculty Member Harald Ott's work in an article about kidney regeneration.
09/18/15 An article in the Boston Globe pictures HSCI Executive Director Brock Reeve, who sat on a panel about gene and cell therapies at the BioPharma America conference.
09/02/15 An article published in the September issue of Discover Magazine features the work of HSCI Principal Faculty member Khalid Shah.
09/02/15 A Fox News article about stem cell tourism references a paper written and a panel organized by the Harvard Stem Cell Institute in 2013.
August 2015
08/12/15 HSCI Principal Faculty member Jeff Karp invents a new hydrogel that targets inflamed tissue and delivers drugs for those with inflammatory bowel disease. Featured: BBC News, Healthline News, Medical Xpress, Helio, FierceBiotech Research, OnMedica
08/11/15 CNN features HSCI Principal Faculty member Harald Ott's limb regeneration work.
08/03/15 HSCI Principal Faculty member Olivier Pourquie's work generating muscle fibers to study muscular dystrophy is featured in Medical Daily.
08/01/15 In an article about nature-inspired bioengineering projects, The Scientist highlights the work of HSCI Principal Faculty member Jeff Karp.
July 2015
07/31/15 An article in The Scientist features the work of HSCI Affiliated Faculty member Luk Vandenberghe, who resurrected the structure of ancient viruses to help improve gene therapy.
June 2015
May 2015
April 2015
04/22/15 HSCI Principal Faculty member George Q. Daley responds to a controversial gene-editing study and furthers public conversation regarding the ethical and moral implications of gene-editing technology. Featured: The New York Times, NPR, Smithsonian, Washington Post, Business Insider, The Seattle Times, Wired, New York Daily News, International Business Times
04/20/15 HSCI Affiliated Faculty member Xiaoliang Sunney Xie is awarded the $500,000 Albany Medical Center Prize in Biomedicine and Biomedical Research. Xie shares the prize with Standford University's Karl Deisseroth. Featured: The Seattle Times, The Washington Post
March 2015
03/25/15 AstraZeneca announces a five-year research collaboration with HSCI to study how beta cell function declines in diabetes. Featured: Wall Street Journal, Bloomberg Business, Reuters, FierceBiotech, Cambridge News, GEN, PharmaTimes
03/24/15 The Boston Globe features Semma Therapeutics, a new biotech company commercializing research from HSCI Co-founder and Principal Faculty member Doug Melton's lab. The company has raised $44 million to begin developing insulin-secreting cell transplant therapies for patients with Type 1 diabetes.
03/19/2015 HSCI Principal Faculty member George Q. Daley comments on the emerging social and ethical implications of gene-editing technology in The New York Times.
03/13/15 A Science news feature about eye transplants mentions HSCI Principal Faculty member Zhigang He's work on optic nerve regeneration.
February 2015
02/26/15 In The Scientist, the latest work in the lab of HSCI Principal Faculty Jeff Karp (Brigham and Women's Hospital/Harvard Medical School) has important implications for improving the efficacy of mesenchymal stem cells (MSCs) used in clinical trials.
January 2015
01/21/15 A Nature news feature on efforts to apply the findings of parabiotic research on mice to humans features HSCI Principal Faculty member Amy Wagers.